BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
MAINZ, Germany, December 8, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference...
News
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB:...
The University of Colorado Anschutz Medical Campus and Orange Grove Bio to Collaborate on Development and Commercialization of Novel Therapies
Collaboration will Leverage Work of World-Class Researchers at CU Anschutz to Grow Colorado Biotech Ecosystem through Company Creation and Drug...
Ikena Appoints Michelle Zhang, Ph.D., Industry and Company Veteran, as Chief Scientific Officer
Dr. Zhang steps into the CSO role after spending more than five years at Ikena in research and development leadership...
Passage Bio Announces Pipeline Expansion and Clinical Program Update
Exercised two additional options with University of Pennsylvania’s Gene Therapy Program aligned with company’s focus on CNS diseases with high...
IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria
– Grant Agreement with the Bill & Melinda Gates Foundation Aims to Leverage IGM’s Engineered IgM and IgA Antibodies to...
Tilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Distillery
Accretive Acquisition of Award-Winning Producer of Distilled Spirits Expands Tilray’s U.S. Offerings into the On-Trend Spirits Category Tilray’s Diversified, Growing...
Pfizer and BioNTech Provide Update on Omicron Variant
Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage), while two...
Proteona announces multiple ASH presentations highlighting novel gene signatures in hematological cancers identified using advanced single-cell biomarker discovery platform
Meet Proteona at ASH 2021 Proteona announced one oral presentation and two poster presentations at ASH 2021 SINGAPORE, Dec. 08,...
Affimed Initiates Patient Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in Combination with Roche’s Anti-PD-L1 Checkpoint Inhibitor Atezolizumab
HEIDELBERG, Germany, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) a clinical-stage immuno-oncology company committed to giving patients...
NeuroSigma Announces a $5 Million Equity Investment by KT Corporation
Signing Ceremony KT Senior EVP and Head of AI/DX Jae-ho Song and NeuroSigma Director, C. Thomas Paschall execute investment documents...
Nexstim Receives an NBS System Order from a Hospital in Germany
Press release, Helsinki, December 8, 2021 at 11:30 AM (EET) Nexstim Receives an NBS System Order from a Hospital in...
MRM Health Announces First Patient Dosed with Next Generation Live Microbiome Consortia Therapeutic MH002 in Phase 1b/2a Study in Patients with Ulcerative Colitis
GHENT, Belgium, Dec. 08, 2021 (GLOBE NEWSWIRE) -- MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics,...
Noema Pharma Hosting Key Opinion Leader Webinar on Stuttering
Friday, December 17th @ 11am ET / 5pm CETBASEL, Switzerland, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Noema Pharma, a Swiss-based...
Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 08, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage...
Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock
MENLO PARK, Calif. and BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company...
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001
Saint-Herblain (France), December 8, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the...
Bone Therapeutics announces closing of private placement
REGULATED INFORMATION NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE...
Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK
Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK Successful...
Cingulate Inc. Announces Pricing of $25.0 Million Initial Public Offering
KANSAS CITY, Kan., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing...
